We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening
Flowbone develops and promotes a biomaterial for the minimal-invasive augmentation of fragile bones at high risk of fracture. Flowbone aims for a world where the elderly can enjoy a high level of independence and quality of life, free from the devastating impact of fragility fractures.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 5, 2022 | Seed | Fr2.10M | — | — | — | Detail |
Sep 27, 2022 | Grant | $100K | 1 |
![]() |
— | Detail |
Jun 7, 2022 | Grant | Fr800K | 1 |
![]() |
— | Detail |
Sep 21, 2021 | Debt Financing | Fr100K | 1 |
![]() |
— | Detail |
Oct 21, 2020 | Non-Equity Assistant | — | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Grant |
![]() |
Yes | Grant |
![]() |
Yes | Debt Financing |
![]() |
Yes | Non-Equity Assistant |
![]() |
— | Grant |